1
|
Nomura H, Mizuno T, Saito K, Yamashita Y, Tamaru S, Oda H, Hiasa A, Kageyama S, Takeuchi T, Katayama N. Skeletal Complications and Survival in Gastric Cancer Patients with Skeletal Metastases. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32459-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
2
|
Hiasa A, Hirayama M, Nishikawa H, Kitano S, Nukaya I, Yu SS, Mineno J, Kato I, Shiku H. Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells. Gene Ther 2008; 15:695-9. [PMID: 18288212 DOI: 10.1038/sj.gt.3303099] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In adoptive T-cell transfer as an intervention for malignant diseases, retroviral transfer of T-cell receptor (TCR) genes derived from CD8(+) cytotoxic T-lymphocyte (CTL) clones provides an opportunity to generate a large number of T cells with the same antigen specificity. We cloned the TCR-alphabeta genes from a human leukocyte antigen (HLA)-A(*)2402-restricted CTL clone specific for MAGE-A4(143-151). The TCR-alphabeta genes were transduced to 99.2% of non-TCR expressing SupT1, a human T-cell line, and to 12.7-32.6% of polyclonally activated CD8(+) T cells by retroviral transduction. As expected, TCR-alphabeta gene-modified CD8(+) T cells showed cytotoxic activity and interferon-gamma production in response to peptide-loaded T2-A(*)2402 and tumor cell lines expressing both MAGE-A4 and HLA-A(*)2402. A total of 24 clones were established from TCR-alphabeta gene-transduced peripheral blood mononuclear cells and all clones were functional on a transduced TCR-dependent manner. Four clones were kept in culture over 6 months for analyses in detail. The transduced TCR-alphabeta genes were stably maintained phenotypically, functionally and genetically. Our results indicate that TCR-transduced alphabeta T cells by retroviral transduction represent an efficient and promising strategy for adoptive T-cell transfer for long term.
Collapse
Affiliation(s)
- A Hiasa
- Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Mie, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Kageyama S, Kitano S, Nagata Y, Hiasa A, Miyahara Y, Imai H, Murphy R, Scott AM, Hoffman EW, Old LJ, Shiku H. Phase I study of CHP-HER2 polyvalent cancer vaccine, HER2 protein combined with a novel nanoparticle antigen delivery system of cholesteryl hydrophobized polysaccharides. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.2523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Kageyama
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - S. Kitano
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - Y. Nagata
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - A. Hiasa
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - Y. Miyahara
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - H. Imai
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - R. Murphy
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - A. M. Scott
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - E. W. Hoffman
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - L. J. Old
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| | - H. Shiku
- Mie Univ, Tsu, Mie, Japan; Nagasaki Univ, Nagasaki, Japan; Ludwig Institute for Cancer Research, Melbourne, Australia; Ludwig Institute for Cancer Research, New York, NY
| |
Collapse
|
4
|
Katoh K, Nomura M, Nakaya Y, Iga A, Nada T, Hiasa A, Ochi Y, Kawaguchi R, Uemura N, Honda H, Shimizu I, Ito S. Autonomic nervous activity before and after eradication of Helicobacter pylori in patients with chronic duodenal ulcer. Aliment Pharmacol Ther 2002; 16 Suppl 2:180-6. [PMID: 11966539 DOI: 10.1046/j.1365-2036.16.s2.27.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
BACKGROUND Helicobacter pylori infection is involved in the formation of chronic peptic ulcer. However, a previously reported hypothesis concerning the involvement of central autonomic nervous disorder in this condition cannot be ruled out. AIM To use spectrum analysis of heart rate viability to examine autonomic nervous activity before and after H. pylori eradication. METHODS Twenty patients with chronic duodenal ulcer (duodenal ulcer group) and 20 age-matched normal adults (N group). In both groups, 24-h Holter electrocardiograms (ECGs) were recorded and spectrum analysis of heartrate variability was performed. In the duodenal ulcer group, Holter ECG was recorded before and after H. pylori eradication. RESULTS In the N group, analysis of heart rate variability showed that high frequency (HF) power, an index of parasympathetic activity, was high at night, while the low frequency (LF)/HF ratio, an index of sympathetic function, was high during the daytime. In the duodenal ulcer group, HF power was higher at night than during the daytime, showing a similar pattern to the N group, but the power value was higher than in the N group (P < 0.05). In the duodenal ulcer group, LF/HF at night was significantly higher than that of the N group. In addition, in the duodenal ulcer group, autonomic activity after H. pylori eradication did not differ significantly from that before H. pylori eradication. CONCLUSIONS In patients with chronic peptic ulcer, both sympatheticotonia and parasympatheticotonia may occur at night, and this abnormality in autonomic nervous activity may cause increased gastric acid secretion and gastric mucosal vasoconstriction. Abnormalities in autonomic activity persist even after H. pylori eradication, suggesting that they may be an independent risk factor in the formation of chronic peptic ulcer in addition to H. pylori infection.
Collapse
Affiliation(s)
- K Katoh
- Second Department of Internal Medicine, and Department of Nutrition, School of Medicine, University of Tokushima, Kuramoto-Cho, Tokushima, Japan
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Hiasa A, Watanabe M, Okada H, Ikenaka K, Fujita T, Yoshimatsu T, Kanematsu T, Shiku H. Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum. Int J Oncol 1999; 14:1091-6. [PMID: 10339663 DOI: 10.3892/ijo.14.6.1091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The complement system of the human body inactivates the infectious ability of retroviruses injected as an artificial gene transfer vector. We established new murine leukemia virus (MuLV) packaging cell lines; D2SS and D7S which express decay-accelerating factor (DAF) on their surface. Both D2SS and D7S were resistant against incubation with fresh human serum. Moreover, the retroviruses produced from these packaging cell lines were also resistant to serum treatment. This resistance can be inhibited by DAF neutralizing antibody 1C6. These data demostrate that DAF induces a partial protection of MuLV infection from the human complement system.
Collapse
Affiliation(s)
- A Hiasa
- Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514-8507, Japan
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Shono M, Shimizu I, Omoya T, Hiasa A, Honda H, Tomita Y, Ito S. Differences in ethidium bromide and 4'-6-diamidino-2-phenylindole staining profiles with regard to DNA fragmentation during apoptosis. Biochem Mol Biol Int 1998; 46:1055-61. [PMID: 9861459 DOI: 10.1080/15216549800204602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
To simply and directly evaluate DNA fragmentation during apoptosis induced in mouse cultured hepatocytes by an anti-Fas antibody, we examined the fluorescence intensity in cell nuclei stained with ethidium bromide and 4'-6-diamidino-2-phenylindole by optiphoto fluorescence microscopy. The intensity of the former staining for the nuclear DNA of apoptotic cells was clearly decreased compared to that of non-apoptotic cells, whereas no difference in the fluorescence intensity for the latter stain between the apoptotic and non-apoptotic groups was observed. Thus, the use of optiphoto fluorescence microscopy, in conjunction with both stains, constitutes a useful tool for the evaluation of apoptotic DNA fragmentation.
Collapse
Affiliation(s)
- M Shono
- General Laboratory for Medical Research, School of Medicine, University of Tokushima, Japan
| | | | | | | | | | | | | |
Collapse
|
7
|
Gu XG, Schmitt M, Hiasa A, Nagata Y, Ikeda H, Sasaki Y, Akiyoshi K, Sunamoto J, Nakamura H, Kuribayashi K, Shiku H. A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. Cancer Res 1998; 58:3385-90. [PMID: 9699670] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
To elicit specific cellular immune responses against cancer, the development of efficient devices to deliver tumor antigen peptides to the MHC class I pathway constitutes a central issue. We report here a novel formula of hydrophobized polysaccharide nanoparticles, which can deliver a HER2 oncoprotein containing an epitope peptide to the MHC class I pathway. A protein consisting of the 147 amino-terminal amino acids of oncogene erbB-2/neu/HER2 (HER2) was complexed with two kinds of hydrophobized polysaccharides, cholesteryl group-bearing mannan (CHM) and cholesteryl group-bearing pullulan (CHP), to form nanoparticles (CHM-HER2 and CHP-HER2). CHM-HER2 and CHP-HER2 were able to induce CD3+/CD8+ CTLs against HER2-transfected syngeneic fibrosarcoma cell lines. In contrast, the oncoprotein alone failed to do so. These CTLs were Kd-restricted and specifically recognized a peptide (position 63-71) that was a part of a truncated HER2 protein used as an immunogen. In addition, vaccination by CHM-HER2 complexes led to a strongly enhanced production of IgG antibodies against HER2, whereas vaccination with HER2 proteins alone resulted in a production of antibodies at a marginal level. Mice immunized with CHM-HER2 or CHP-HER2 before tumor challenge successfully rejected HER2-transfected tumors. The complete rejection of tumors also occurred when CHM-HER2 was applied not later than 3 days after tumor implantation. In the effector phase of in vivo tumor rejection, CD8+ T cells played a major role. The results suggest that a sort of hydrophobized polysaccharide may help soluble proteins to induce cellular immunity as well enhance humoral immunity; hence, such a novel vaccine may be of potential benefit to cancer prevention and cancer therapy.
Collapse
Affiliation(s)
- X G Gu
- Second Department of Internal Medicine, Mie University School of Medicine, Edobashi, Tsu, Japan.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Kihira H, Hiasa A, Yamamoto M, Katayama N, Kuno T, Ohtsuka K, Shiku H, Nishikawa M. Possible involvement of calcineurin in retinoic acid-induced inhibition of leukemic HL-60 cell proliferation. Int J Oncol 1998; 12:629-34. [PMID: 9472103 DOI: 10.3892/ijo.12.3.629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Differentiation of leukemic HL-60 cells by all transretinoic acid (ATRA) resulted in a reduced rate of growth. Cyclosporin A and FK506, at concentrations that inhibited calcineurin activity, abrogated the ATRA-induced inhibition of HL-60 cell growth but these immunosuppressants had no effect on the ATRA-induced granulocytic differentiation. Treatment with 1 microM ATRA led to a progressive increase in calcineurin phosphatase activity of HL-60 cells; the increase in this activity appeared to parallel the functional change of HL-60 cells during granulocytic differentiation. Increase in calcineurin activity was concordant with the increased expressions of calcineurin A and calcineurin B subunit proteins. The FKBP12 expression increased during ATRA-induced differentiation and expression of cyclophilin A remained unchanged. We propose that the increased expression of calcineurin is involved in the ATRA-induced inhibition of HL-60 cell proliferation, as in the case with 1,25alpha-dihydroxy-vitamin D3.
Collapse
Affiliation(s)
- H Kihira
- The Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie 514, Japan
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, Kita K, Shiku H. De novo CD5+ diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 1998; 91:1145-51. [PMID: 9454743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
To clarify the cellular origin of de novo CD5+ diffuse large B-cell lymphoma (CD5+ DLBL), particularly in comparison with other CD5+ B-cell neoplasms such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), we analyzed the nucleotide sequence of the Ig heavy chain variable region (IgVH) genes of de novo CD5+ DLBL cases. All 4 cases examined had extensive somatic mutations in contrast with CLL or MCL. The VH gene sequences of de novo CD5+ DLBL displayed 86.9% to 95.2% homology with the corresponding germlines, whereas those of simultaneously analyzed CLL and MCL displayed 97.6% to 100% homology. The VH family used was VH3 in 1 case, VH4 in 2 cases, and VH5 in 1 case. In 2 of 4 examined cases, the distribution of replacement and silent mutations over the complementarity determining region and framework region in the VH genes was compatible with the pattern resulting from the antigen selection. Clinically, CD5+ DLBL frequently involved a variety of extranodal sites (12/13) and lymph node (11/13). Immunophenotypically, CD5+ DLBL scarcely expressed CD21 and CD23 (3/13 and 2/13, respectively). These findings indicate that de novo CD5+ DLBL cells are derived from a B-1 subset distinct from those of CLL or MCL.
Collapse
Affiliation(s)
- M Taniguchi
- The Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan
| | | | | | | | | | | | | |
Collapse
|
10
|
Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, Furukawa K, Nakamura H, Furukawa K, Kanematsu T, Shiku H. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. J Immunol 1997; 159:1336-43. [PMID: 9233630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
In this analysis, we examined whether peptides derived from a wild-type murine proto-oncogene, c-erbB-2, function as tumor rejection Ags. Expression of murine c-erbB-2 examined by means of reverse transcription-PCR was observed in several normal adult tissues, such as intestine, kidney, and testis. We then transduced human and murine c-erbB-2 cDNA into two mutually noncross-reactive fibrosarcoma lines of BALB/c origin, CMS7 and CMS17. In BALB/c mice immunized with CMS17HE (CMS17 transduced with human c-erbB-2 cDNA), the growth of subsequently challenged CMS7HE (CMS7 transduced with human c-erbB-2 cDNA) was significantly suppressed. CTL against human c-erbB-2-expressing cells were generated from BALB/c spleen cells in vivo and in vitro sensitized by CMS17HE. The CTL activity was also directed against murine c-erbB-2-expressing cells, CMS7ME and CMS17ME, and was blocked by anti-CD8 or anti-Kd mAbs. A series of peptides of human or murine c-erbB-2 compatible with the Kd binding motif was synthesized. The CTL were reactive with P1.HTR (H-2d) pulsed with three of these peptides, p63-71 (human c-erbB-2 derived), p63-71(A) (murine c-erbB-2 derived), and p780-788 (common for human and murine c-erbB-2). Spleen cells immunized in vivo and in vitro with syngeneic spleen cells pulsed with these peptides became cytotoxic for CMS17HE and/or CMS17ME, but not CMS17neo (CMS17 transduced with control vector). The growth of CMS7ME was suppressed in mice immunized with the murine c-erbB-2-derived peptide, p63-71(A) or p780-788. There was no apparent pathologic change in mice that rejected CMS7ME after vaccination with these peptides.
Collapse
MESH Headings
- 3T3 Cells
- Amino Acid Sequence
- Animals
- Antineoplastic Agents/immunology
- Antineoplastic Agents/pharmacology
- Cloning, Molecular
- Cytotoxicity, Immunologic/drug effects
- Female
- Fibrosarcoma/genetics
- Gene Expression Regulation, Neoplastic/immunology
- Growth Inhibitors/immunology
- H-2 Antigens/biosynthesis
- H-2 Antigens/genetics
- Humans
- Immunosuppressive Agents/pharmacology
- Immunotherapy, Active
- Lymphocyte Activation/drug effects
- Mast-Cell Sarcoma
- Methylcholanthrene
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C3H
- Mice, Inbred DBA
- Molecular Sequence Data
- Peptide Fragments/adverse effects
- Peptide Fragments/immunology
- Peptide Fragments/therapeutic use
- Proto-Oncogene Mas
- Receptor, ErbB-2/adverse effects
- Receptor, ErbB-2/genetics
- Receptor, ErbB-2/immunology
- T-Lymphocytes, Cytotoxic/drug effects
- T-Lymphocytes, Cytotoxic/immunology
- Transfection/immunology
- Tumor Cells, Cultured
Collapse
Affiliation(s)
- Y Nagata
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Nagata Y, Furugen R, Hiasa A, Ikeda H, Ohta N, Furukawa K, Nakamura H, Furukawa K, Kanematsu T, Shiku H. Peptides derived from a wild-type murine proto-oncogene c-erbB-2/HER2/neu can induce CTL and tumor suppression in syngeneic hosts. The Journal of Immunology 1997. [DOI: 10.4049/jimmunol.159.3.1336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
In this analysis, we examined whether peptides derived from a wild-type murine proto-oncogene, c-erbB-2, function as tumor rejection Ags. Expression of murine c-erbB-2 examined by means of reverse transcription-PCR was observed in several normal adult tissues, such as intestine, kidney, and testis. We then transduced human and murine c-erbB-2 cDNA into two mutually noncross-reactive fibrosarcoma lines of BALB/c origin, CMS7 and CMS17. In BALB/c mice immunized with CMS17HE (CMS17 transduced with human c-erbB-2 cDNA), the growth of subsequently challenged CMS7HE (CMS7 transduced with human c-erbB-2 cDNA) was significantly suppressed. CTL against human c-erbB-2-expressing cells were generated from BALB/c spleen cells in vivo and in vitro sensitized by CMS17HE. The CTL activity was also directed against murine c-erbB-2-expressing cells, CMS7ME and CMS17ME, and was blocked by anti-CD8 or anti-Kd mAbs. A series of peptides of human or murine c-erbB-2 compatible with the Kd binding motif was synthesized. The CTL were reactive with P1.HTR (H-2d) pulsed with three of these peptides, p63-71 (human c-erbB-2 derived), p63-71(A) (murine c-erbB-2 derived), and p780-788 (common for human and murine c-erbB-2). Spleen cells immunized in vivo and in vitro with syngeneic spleen cells pulsed with these peptides became cytotoxic for CMS17HE and/or CMS17ME, but not CMS17neo (CMS17 transduced with control vector). The growth of CMS7ME was suppressed in mice immunized with the murine c-erbB-2-derived peptide, p63-71(A) or p780-788. There was no apparent pathologic change in mice that rejected CMS7ME after vaccination with these peptides.
Collapse
Affiliation(s)
- Y Nagata
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - R Furugen
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - A Hiasa
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - H Ikeda
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - N Ohta
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - K Furukawa
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - H Nakamura
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - K Furukawa
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - T Kanematsu
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | - H Shiku
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| |
Collapse
|
12
|
Motojima K, Komuta K, Hiasa A, Tsuribune T, Hashimoto T, Tsunoda T, Kanematsu T. [Evaluation of immunoreactivity to erbB-2 protein as a marker of prognosis in bile duct carcinoma]. Nihon Geka Gakkai Zasshi 1992; 93:952-5. [PMID: 1361658] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/25/2023]
Abstract
Recent studies of erbB-2 expression have shown that the erbB-2 oncoprotein correlated with poor prognosis of patients with breast cancer. Surgical treatment of the bile duct carcinoma is currently unsatisfactory. To evaluate erbB-2 oncoprotein as a marker of prognosis, we analyzed 68 bile duct carcinomas immunohistologically, using monoclonal antibody against erbB-2 oncoprotein, as well as clinicopathological data and outcome. High incidence of expression of erbB-2 oncoprotein was shown in bile duct carcinoma. Positive rates of erbB-2 oncoprotein correlated with stage of bile duct carcinoma. Survival of patients with erbB-2 expression cancer was shorter than those without erbB-2 expression cancer and erbB-2 expression has a prognostic value in bile duct carcinoma.
Collapse
Affiliation(s)
- K Motojima
- Second Department of Surgery, Nagasaki University School of Medicine, Japan
| | | | | | | | | | | | | |
Collapse
|